135 related articles for article (PubMed ID: 38240078)
21. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes.
Sjödahl G; Abrahamsson J; Holmsten K; Bernardo C; Chebil G; Eriksson P; Johansson I; Kollberg P; Lindh C; Lövgren K; Marzouka NA; Olsson H; Höglund M; Ullén A; Liedberg F
Eur Urol; 2022 May; 81(5):523-532. PubMed ID: 34782206
[TBL] [Abstract][Full Text] [Related]
22. Multicenter Validation of Histopathologic Tumor Regression Grade After Neoadjuvant Chemotherapy in Muscle-invasive Bladder Carcinoma.
Voskuilen CS; Oo HZ; Genitsch V; Smit LA; Vidal A; Meneses M; Necchi A; Colecchia M; Xylinas E; Fontugne J; Sibony M; Rouprêt M; Lenfant L; Côté JF; Buser L; Saba K; Furrer MA; van der Heijden MS; Daugaard M; Black PC; van Rhijn BWG; Hendricksen K; Poyet C; Seiler R
Am J Surg Pathol; 2019 Dec; 43(12):1600-1610. PubMed ID: 31524642
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence.
Daneshmand S; Nazemi A
Eur Urol Focus; 2020 Jul; 6(4):639-641. PubMed ID: 32451316
[TBL] [Abstract][Full Text] [Related]
24. Pathologic reporting practices for breast cancer specimens after neoadjuvant chemotherapy-a survey of pathologists in academic institutions across the United States.
Lanjewar S; Patil P; Fineberg S
Mod Pathol; 2020 Jan; 33(1):91-98. PubMed ID: 31383962
[TBL] [Abstract][Full Text] [Related]
25. Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.
Kitamura H; Hinotsu S; Tsukamoto T; Shibata T; Mizusawa J; Kobayashi T; Miyake M; Nishiyama N; Kojima T; Nishiyama H;
Jpn J Clin Oncol; 2020 Dec; 50(12):1464-1469. PubMed ID: 32699909
[TBL] [Abstract][Full Text] [Related]
26. Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.
Gopalakrishnan D; Elsayed AS; Hussein AA; Jing Z; Li Q; Wagner AA; Aboumohamed A; Roupret M; Balbay D; Wijburg C; Stockle M; Dasgupta P; Khan MS; Wiklund P; Hosseini A; Peabody J; Shigemura K; Trump D; Guru KA; Chatta G
Int J Urol; 2022 Mar; 29(3):197-205. PubMed ID: 34923677
[TBL] [Abstract][Full Text] [Related]
27. Complete response of bony metastatic bladder urothelial cancer to neoadjuvant chemotherapy and cystectomy.
Joudi FN; Dahmoush L; Spector DM; Konety BR
Urol Oncol; 2006; 24(5):403-6. PubMed ID: 16962489
[TBL] [Abstract][Full Text] [Related]
28. [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].
Pignot G; Houédé N; Roumiguié M; Audenet F; Brunelle S; Colin P; Compérat E; Larré S; Masson-Lecomte A; Neuzillet Y; Xylinas E; Méjean A; Rouprêt M;
Prog Urol; 2018 Oct; 28(12):567-574. PubMed ID: 30205925
[TBL] [Abstract][Full Text] [Related]
29. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Becker REN; Meyer AR; Brant A; Reese AC; Biles MJ; Harris KT; Netto G; Matoso A; Hoffman-Censits J; Hahn NM; Choi W; McConkey D; Pierorazio PM; Johnson MH; Schoenberg MP; Kates MR; Baras A; Bivalacqua TJ
Eur Urol; 2021 Mar; 79(3):364-371. PubMed ID: 32814637
[TBL] [Abstract][Full Text] [Related]
30. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer.
Meeks JJ; Bellmunt J; Bochner BH; Clarke NW; Daneshmand S; Galsky MD; Hahn NM; Lerner SP; Mason M; Powles T; Sternberg CN; Sonpavde G
Eur Urol; 2012 Sep; 62(3):523-33. PubMed ID: 22677572
[TBL] [Abstract][Full Text] [Related]
31. Neoadjuvant chemotherapy preceding cystectomy for bladder cancer.
Sonpavde G; Amiel GE; Mims MP; Hayes TG; Lerner SP
Expert Opin Pharmacother; 2008 Aug; 9(11):1885-93. PubMed ID: 18627327
[TBL] [Abstract][Full Text] [Related]
32. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.
Hamid ARAH; Ridwan FR; Parikesit D; Widia F; Mochtar CA; Umbas R
BMC Urol; 2020 Oct; 20(1):158. PubMed ID: 33054762
[TBL] [Abstract][Full Text] [Related]
33. Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.
Herr HW; Scher HI
J Clin Oncol; 1994 May; 12(5):975-80. PubMed ID: 8164050
[TBL] [Abstract][Full Text] [Related]
34. A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience.
Dash A; Pettus JA; Herr HW; Bochner BH; Dalbagni G; Donat SM; Russo P; Boyle MG; Milowsky MI; Bajorin DF
Cancer; 2008 Nov; 113(9):2471-7. PubMed ID: 18823036
[TBL] [Abstract][Full Text] [Related]
35. The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
Murasawa H; Koie T; Ohyama C; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Iwabuchi I; Ogasawara M; Kawaguchi T
Int J Clin Oncol; 2017 Feb; 22(1):159-165. PubMed ID: 27534866
[TBL] [Abstract][Full Text] [Related]
36. Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology.
Kaimakliotis HZ; Monn MF; Cho JS; Pedrosa JA; Hahn NM; Albany C; Gellhaus PT; Cary KC; Masterson TA; Foster RS; Bihrle R; Cheng L; Koch MO
Future Oncol; 2016 Aug; 12(15):1795-804. PubMed ID: 27255805
[TBL] [Abstract][Full Text] [Related]
37. [The prognostic value of adjuvant and neoadjuvant chemotherapy in total cystectomy for locally advanced bladder cancer].
Habuchi T; Kakehi Y; Terachi T; Ogawa O; Yoshida O
Nihon Hinyokika Gakkai Zasshi; 1999 Oct; 90(10):809-17. PubMed ID: 10565159
[TBL] [Abstract][Full Text] [Related]
38. Delivery of perioperative chemotherapy for bladder cancer in routine clinical practice.
Booth CM; Siemens DR; Peng Y; Tannock IF; Mackillop WJ
Ann Oncol; 2014 Sep; 25(9):1783-1788. PubMed ID: 24915872
[TBL] [Abstract][Full Text] [Related]
39. Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710).
Scosyrev E; Ely BW; Messing EM; Speights VO; Grossman HB; Wood DP; de Vere White RW; Vogelzang NJ; Trump DL; Natale RB; Tangen CM; Crawford ED; Thompson IM
BJU Int; 2011 Sep; 108(5):693-9. PubMed ID: 21105991
[TBL] [Abstract][Full Text] [Related]
40. [Chemotherapy for urothelial cancer of the bladder--update 2012].
Niegisch G; Lorch A; Albers P
Aktuelle Urol; 2012 Dec; 43(6):412-9. PubMed ID: 23196781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
